VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COMy 2021 | Current state of the art for WM

Chemoimmunotherapy represents a tried a tested approach to Waldenström’s macroglobulinemia (WM). Jorge Castillo, MD, Dana-Farber Cancer Institute, Boston, MA, talks on the current state of the art for WM management, commenting on the increasing number of agents physicians have at their disposal and the subsequent positive impact this has on patient outcomes. This interview took place during the 7th World Congress on Controversies in Multiple Myeloma (COMy), 2021.

Disclosures

Jorge Castillo receives research funds and/or honoraria from Abbvie, Beigene, Janssen, Pharmacyclics, Roche, TG Therapeutics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter